A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors.
Agata MlynskaRamunė VaišnorėVytautas RafanavičiusSimonas JocysJulija JaneikoMonika PetrauskytėSimas BijeikisPiotras CimmpermanBirutė IntaitėKarolina ŽilionytėAušrinė BarakauskienėRaimundas MeškauskasEmilija PaberalėVita PašukonienėPublished in: American journal of reproductive immunology (New York, N.Y. : 1989) (2020)
Our results highlight the presence of transcriptionally and histologically distinct immune subtypes among ovarian tumors and emphasize the potential benefit of immune subtyping as a clinical tool for treatment tailoring.